Plasma p-tau181, Aβ1-42, and GFAP across Alzheimer’s disease, mixed-type Alzheimer’s disease, mild cognitive impairment, anxiety disorders, and depressive disorders

Brain Research · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles